Recent Updates
Recently added Catalysts
JAZZ

Jazz Pharmaceuticals to Report 2017 Fourth Quarter and Full Year Financial Results on February 27, 2018 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2017 fourth quarter and full year financial results on Tuesday,...

Key Takeaway: DUBLIN , Feb. 13, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that it will report its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018 , after the close of the financial markets. Company management will host a liv

Full Press Release Details

DUBLIN , Feb. 13, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that it will report its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018 , after the close of the financial markets. Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST / 9:30 p.m. GMT to discuss fourth quarter and full year 2017 financial results and provide a business and financial update and guidance for 2018 financial results.
Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least one week.
Audio webcast/conference call: U.S. Dial-In Number: +1 855 353 7924 International Dial-In Number: +1 503 343 6056 Passcode: 4179828
A replay of the conference call will be available through March 6, 2018 and accessible through one of the following telephone numbers, using the passcode below:
Replay U.S. Dial-In Number: +1 855 859 2056 Replay International Dial-In Number: +1 404 537 3406 Passcode: 4179828
SOURCE Jazz Pharmaceuticals plc

Related Links

21 %

Last updated: Feb 13, 2018